Related Experiment Video
Updated: Jul 8, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Toward cell-based therapy of type I diabetes
Dieter Kabelitz1, Edward K Geissler, Bernat Soria
1Institute of Immunology, University Hospital Schleswig-Holstein, Kiel, Germany. kabelitz@immunologie.uni-kiel.de
Trends in Immunology
|January 10, 2008
Summary
Type 1 diabetes (T1D) cell therapies aim to replace destroyed insulin-producing cells or restore immune tolerance. Combining both strategies is crucial for successful clinical treatment of T1D.
Area of Science:
- Immunology
- Endocrinology
- Regenerative Medicine
Background:
- Type 1 diabetes (T1D) is an autoimmune disease targeting insulin-producing pancreatic islet cells.
- Current treatments include insulin therapy and transplantation, with limited long-term success.
- Autoreactive T cells drive islet cell destruction in T1D.
Purpose of the Study:
- To review the current status of cell-based therapies for Type 1 diabetes.
- To explore strategies for replacing lost islet cells and re-establishing immune tolerance.
- To highlight the potential of combined therapeutic approaches for T1D.
Main Methods:
- Review of existing research on stem cell-derived islet-like cells.
- Analysis of regulatory T cell and tolerance-promoting cell strategies.
- Discussion of combined cell-based therapeutic approaches for T1D.
Main Results:
- Stem cell-derived cells offer a potential source for islet cell replacement.
- Regulatory T cells and tolerance-promoting cells show promise in preventing immune attack.
- Combining cell replacement and immune tolerance strategies is essential for T1D cure.
Conclusions:
- Cell-based therapies hold significant promise for Type 1 diabetes treatment.
- Replacing islet cells and restoring immune tolerance are key therapeutic goals.
- A combination of cell replacement and immune modulation is necessary for clinical success in T1D.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.